These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36041209)

  • 21. DSCAM-AS1 accelerates cell proliferation and migration in osteosarcoma through miR-186-5p/GPRC5A signaling.
    Ning Y; Bai Z
    Cancer Biomark; 2021; 30(1):29-39. PubMed ID: 32865178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
    Zhou Y; Feng D; Gu X; Gao A; Liu Y
    Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA FGD5-AS1 Alleviates Inflammation in Allergic Rhinitis through the miR-223-3p/COX11 Axis.
    Li B; Yu X; Pang F
    Int Arch Allergy Immunol; 2024; 185(3):201-211. PubMed ID: 38071964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA FGD5-AS1 promotes non-small cell lung cancer cell proliferation through sponging hsa-miR-107 to up-regulate FGFRL1.
    Fan Y; Li H; Yu Z; Dong W; Cui X; Ma J; Li S
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31919528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FXR1 promotes glioma progression by downregulating microRNA-124-3p through long noncoding RNA FGD5-AS1 upregulation.
    Gong X; Huang M; Chen L; Zeng H
    Acta Neurol Belg; 2023 Aug; 123(4):1453-1464. PubMed ID: 37074635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long noncoding RNA FGD5-AS1 alleviates childhood IgA nephropathy by targeting PTEN-mediated JNK/c-Jun signaling pathway via miR-196b-5p.
    Sun Q; Liu X; Wang M; Fan J; Zeng H
    Exp Cell Res; 2023 Mar; 424(1):113481. PubMed ID: 36641136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PITPNA-AS1 abrogates the inhibition of miR-876-5p on WNT5A to facilitate hepatocellular carcinoma progression.
    Sun J; Zhang Y; Li B; Dong Y; Sun C; Zhang F; Jin L; Chen D; Wang W
    Cell Death Dis; 2019 Nov; 10(11):844. PubMed ID: 31700026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA FOXD2-AS1 knockdown inhibits the resistance of human osteosarcoma cells to cisplatin by inhibiting miR-143 expression.
    Zhang QQ; Xu SL; Ding C; Ma CC; Yuan TS; Hua CC; Wang XH
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):678-686. PubMed ID: 33577022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of FGD5-AS1 Promotes Progression of Cervical Cancer through Regulating BST2 to Inhibit Macrophage M1 Polarization.
    Liu G; Du X; Xiao L; Zeng Q; Liu Q
    J Immunol Res; 2021; 2021():5857214. PubMed ID: 34692852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. lncRNA FGD5-AS1 Regulates Bone Marrow Stem Cell Proliferation and Apoptosis by Affecting miR-296-5p/STAT3 Axis in Steroid-Induced Osteonecrosis of the Femoral Head.
    Wu Y; Fang L; Gao Y; Zhao Z; Zhou L; Zhang G
    J Healthc Eng; 2022; 2022():9364467. PubMed ID: 35190765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upregulation of Long Noncoding RNA FGD5-AS1 Ameliorates Myocardial Ischemia/Reperfusion Injury via MicroRNA-106a-5p and MicroRNA-106b-5p.
    Hao L; Wang J; Bi SJ; Cheng C
    J Cardiovasc Pharmacol; 2021 Jul; 78(1):e45-e54. PubMed ID: 34173804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA DICER1-AS1 promotes the proliferation, invasion and autophagy of osteosarcoma cells via miR-30b/ATG5.
    Gu Z; Hou Z; Zheng L; Wang X; Wu L; Zhang C
    Biomed Pharmacother; 2018 Aug; 104():110-118. PubMed ID: 29772430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LncRNA RGMB-AS1 up-regulates ANKRD1 Through Competitively Sponging miR-3614-5p to Promote OSA Cell Proliferation and Invasion.
    Yin P; Tong C
    Arch Med Res; 2022 Feb; 53(2):131-137. PubMed ID: 34583851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal expression of long non-coding RNA FGD5-AS1 affects the development of ovarian cancer through regulating miR-107/RBBP6 axis.
    Zhang W; Shi J; Liu G
    Chin J Physiol; 2023; 66(3):171-180. PubMed ID: 37322627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA RUSC1-AS1 promotes osteosarcoma progression through regulating the miR-340-5p and PI3K/AKT pathway.
    Tong CJ; Deng QC; Ou DJ; Long X; Liu H; Huang K
    Aging (Albany NY); 2021 May; 13(16):20116-20130. PubMed ID: 34048366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. lncRNA MSC-AS1 activates Wnt/β-catenin signaling pathway to modulate cell proliferation and migration in kidney renal clear cell carcinoma via miR-3924/WNT5A.
    Hu Z; Li L; Cheng P; Liu Q; Zheng X; Peng F; Zhang Q
    J Cell Biochem; 2020 Oct; 121(10):4085-4093. PubMed ID: 31916281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA PRKCQ-AS1 regulates paclitaxel resistance in triple-negative breast cancer cells through miR-361-5p/PIK3C3 mediated autophagy.
    Zheng S; Fu W; Huang Q; Zhou J; Lu K; Gu J; Ma R; Guo G
    Clin Exp Pharmacol Physiol; 2023 Jun; 50(6):431-442. PubMed ID: 36732923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thalidomide suppresses angiogenesis and immune evasion via lncRNA FGD5-AS1/miR-454-3p/ZEB1 axis-mediated VEGFA expression and PD-1/PD-L1 checkpoint in NSCLC.
    Xia Y; Wang WC; Shen WH; Xu K; Hu YY; Han GH; Liu YB
    Chem Biol Interact; 2021 Nov; 349():109652. PubMed ID: 34520751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA TTN-AS1 regulates osteosarcoma cell apoptosis and drug resistance via the miR-134-5p/MBTD1 axis.
    Fu D; Lu C; Qu X; Li P; Chen K; Shan L; Zhu X
    Aging (Albany NY); 2019 Oct; 11(19):8374-8385. PubMed ID: 31600142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.